
KalVista Pharmaceuticals KALV
€ 22.84
-0.02%
Geschäftsbericht 2025
hinzugefügt 25.03.2026
KalVista Pharmaceuticals P/CF 2011-2026 | KALV
P/CF Jährlich KalVista Pharmaceuticals
| 2025 | 2024 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.2 | -8.34 | -8.23 | -4.43 | -9.27 | 9.5 | -1.39 | -0.666 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 9.5 | -10.2 | -4.13 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.3 | $ 9.13 | -0.76 % | $ 591 M | ||
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-3.64 | $ 0.91 | 2.42 % | $ 6.69 M | ||
|
Edesa Biotech
EDSA
|
-1.24 | $ 15.52 | -2.39 % | $ 49.6 M | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
20.2 | $ 22.47 | 1.19 % | $ 3.72 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
Fortress Biotech
FBIO
|
-1.18 | $ 2.24 | 0.9 % | $ 62.5 M | ||
|
Galectin Therapeutics
GALT
|
-7.47 | $ 2.26 | 0.22 % | $ 144 M | ||
|
Galapagos NV
GLPG
|
-8.78 | $ 28.07 | 0.75 % | $ 2.69 B | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Grifols, S.A.
GRFS
|
14.1 | $ 8.2 | 3.6 % | $ 6.83 B | ||
|
Harmony Biosciences Holdings
HRMY
|
4.62 | $ 31.01 | -0.13 % | $ 1.78 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
ImmuCell Corporation
ICCC
|
23.4 | $ 8.44 | - | $ 76.2 M | ||
|
InflaRx N.V.
IFRX
|
-3.72 | $ 1.95 | -1.77 % | $ 152 M | ||
|
Immuron Limited
IMRN
|
-274 | $ 0.83 | 3.44 % | $ 6.55 M | ||
|
Incyte Corporation
INCY
|
13.8 | $ 98.87 | -0.23 % | $ 19.3 B | ||
|
InMed Pharmaceuticals
INM
|
-0.235 | $ 0.71 | 1.28 % | $ 1.74 M | ||
|
INmune Bio
INMB
|
-1.25 | $ 1.35 | 1.5 % | $ 33.4 M | ||
|
Innoviva
INVA
|
8.24 | $ 23.13 | 0.35 % | $ 1.56 B | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | ||
|
BioNTech SE
BNTX
|
70.7 | $ 104.54 | 2.92 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | ||
|
Jaguar Health
JAGX
|
-0.0404 | $ 7.55 | -4.13 % | $ 17.6 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Innate Pharma S.A.
IPHA
|
-6.2 | $ 1.43 | -4.03 % | $ 235 M | ||
|
Kamada Ltd.
KMDA
|
-30.7 | $ 8.15 | 0.49 % | $ 260 M | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | ||
|
Kazia Therapeutics Limited
KZIA
|
-5.82 | $ 13.24 | 6.56 % | $ 1.75 B | ||
|
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
22.9 | $ 223.98 | -0.39 % | $ 4.1 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 3.22 | 7.69 % | $ 5.3 M | ||
|
Liquidia Corporation
LQDA
|
-82.6 | $ 38.39 | 0.62 % | $ 3.3 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Applied Therapeutics
APLT
|
-9.8 | - | - | $ 8.42 M | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
Aquestive Therapeutics
AQST
|
-8.91 | $ 4.08 | 0.74 % | $ 436 M |